Skip to main content
. 2022 Feb 18;13:802671. doi: 10.3389/fmicb.2022.802671

TABLE 3.

IC50 of SMeFM for the propagation of influenza virus clinical isolates with low susceptibility to anti-influenza drugs.

Strain IC50 (nM)*
A/KANAGAWA/IC1890/2019 (H1N1pdm09, PA I38T) 79.2 ± 26.6
A/KANAGAWA/ZC1905/2019 (H1N1pdm09, NA H275Y) 55.4 ± 26.7
A/KITAKYUSYU/36/2015 (H3N2, NA E119V) 31.4 ± 16.5

*The half-maximal inhibitory concentration (IC50) was determined from the result of the plaque assay. Average values with standard deviations from three independent experiments were shown.